SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (570)5/15/1997 2:40:00 AM
From: Rocketman   of 9719
 
The transgenic business was the reason that Dolly the sheep was cloned. In transgenics, it is hard to reproduce the good producers and is generally hit and miss, as the capability is added to the animal and not a breeding characteristic. Now that the ability to clone has been proven, when this has been made a routine process, they will be able to mass produce the optimal protein producers consistently in a much more direct and economical fashion than is currently possible. Also, the cows are still a bit out there. Much transgenic work is done is smaller animals for the convenience that they afford in research. While cows produce more milk, they are also alot bigger and more expensive to maintain. That's the reason that the latest breakthrough in excretion has been demonstrated in a mouse system. Now that they know how to do it in a mammal, they will adapt the system to larger mammals.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News